AgeX Therapeutics Inc (AGE): AgeX Therapeutics shares are trading hig...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	800
Posts	50862
Boards Moderated	2
Alias Born	12/12/2004

crudeoil24

Re: Good Timer post# 60

Thursday, 10/08/2020 2:27:43 PM

Thursday, October 08, 2020 2:27:43 PM

AgeX Therapeutics shares are trading higher following an amended 13D filing showing Juvenescence Limited has a 50% stake in the company.

AGE

New York Yankees and Duke Basketball

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent AGE News

AgeX Therapeutics Reports Fourth Quarter and Annual 2023 Financial Results • GlobeNewswire Inc. • 03/22/2024 09:27:00 PM
Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 03/07/2024 09:49:59 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 09:47:08 PM
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 03/07/2024 12:47:43 PM
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/14/2024 09:01:43 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/14/2024 05:15:21 AM
Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 09:05:20 PM
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/05/2024 12:19:04 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:05:39 PM
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 01/17/2024 09:19:13 PM
Form S-4/A - Registration of securities, business combinations: [Amend] • Edgar (US Regulatory) • 01/16/2024 02:11:27 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/11/2024 09:05:36 PM
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 01/09/2024 09:16:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 09:05:32 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 09:02:11 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/18/2023 09:25:54 PM
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 12/13/2023 10:11:13 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/08/2023 09:05:43 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/01/2023 09:05:25 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/17/2023 09:05:38 PM
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 11/16/2023 09:01:20 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/15/2023 02:38:49 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2023 09:25:21 PM
AgeX Therapeutics Reports Third Quarter 2023 Financial Results • Business Wire • 11/14/2023 09:05:00 PM

More AGE News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover